ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1178

Can Immersive Virtual Reality Improve the Effect of Meditation for People with Fibromyalgia?

Nancy Baker1, Aliza Spielman1 and Robert Edwards2, 1Tufts University, Medford, 2Brigham and Women's Hospital, Boston, MA

Meeting: ACR Convergence 2024

Keywords: fibromyalgia, pain, Therapy, complementary

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 17, 2024

Title: Orthopedics, Low Back Pain, & Rehabilitation – ACR/ARP Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Fibromyalgia (FM) is a common and disabling condition characterized by widespread muscular pain. Meditation has been shown to alleviate affective pain in people with chronic pain1 but may be less effective for those with FM2. Immersive virtual reality (IVR) has been shown to significantly affect pain3.  In this pilot study we hypothesized that IVR enhanced meditation (IVRm) would have a greater effect on pain, affect and physiological outcomes than non-immersive meditation (NIm).

Methods: We recruited 9 females with FM. In this cross-over RCT design participants were randomly assigned the order in which they received two interventions over two visits with at least 48 hours between. In IVRm participants took part in a 10-minute guided meditation while participants were immersed in a virtual beautiful and peaceful environment of their choice via a headset (Oculus Rift S). In NIm participants did the same 10-minute guided meditation while watching the same environment on a computer screen.  Before and after the meditation, pain intensity was obtained using a standard numerical rating scale (NRS) and affect using the Positive and Negative Affect Scale (PANAS). We measured physiological vital signs of heart rate (HR) and blood pressure from which we calculated the average mean arterial pressure (MAP).  We also measured the meditation experience using the Meditation Experience Questionnaire (MEQ)

Data Analysis: Because this was a pilot study we calculated the effect size r, and interpreted results as follows: negligible < 0.10; small 0.10-0.29; moderate 0.30-0.49; large ≥ 0.50.

Results: Meditation had negligible effects on pain for both groups. It had moderate positive effects on HR and affect, and large positive effects on blood pressure. Generally, the difference between groups was negligible, however people in the IVRm group demonstrated moderately greater changes in negative affect than those in the NIm group (See Table). For the MEQ people reported moderately fewer distractions while using IVRm, including less mind wandering (r = 0.31), awareness of the body (r = 0.32) and bodily discomfort (r = 0.40)

Conclusion: Meditation in general does not appear to strongly affect pain in people with FM although immersive meditation does reduce awareness of bodily discomfort better than non-immersive meditation.  Meditation has positive effects on other important outcomes such as affect and vital signs. IVR appears to provide the most support in reducing negative emotions such as distress, irritability, and fear and may provide a less distracting environment than its non-immersive counterpart.

References

1.         Ball EF, et al. Does mindfulness meditation improve chronic pain? A systematic review. Curr Opin Obstet Gyn. 2017;29(6)

2.         Hennard J. A protocol and pilot study for managing fibromyalgia with yoga and meditation. Int J Yoga Therap. 2011;(21):109-21.

3.         Baker NA, et al. The state of science in the use of virtual reality in the treatment of acute and chronic pain: A systematic scoping review. Clin J Pain. 2022;38(6):424-441.

Supporting image 1


Disclosures: N. Baker: None; A. Spielman: None; R. Edwards: None.

To cite this abstract in AMA style:

Baker N, Spielman A, Edwards R. Can Immersive Virtual Reality Improve the Effect of Meditation for People with Fibromyalgia? [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/can-immersive-virtual-reality-improve-the-effect-of-meditation-for-people-with-fibromyalgia/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/can-immersive-virtual-reality-improve-the-effect-of-meditation-for-people-with-fibromyalgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology